Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells.

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia.

Our most recent data indicates that insiders own some shares in Cantargia AB (publ). In their own names, insiders own kr16m worth of stock in the kr1.5b company. Ownership is clearly an important issue when it comes to investment selection. However, there are many other factors to consider, such as the risks within the company itself.

Cantargia ab stock

Ownership is clearly an important issue when it comes to investment selection. However, there are many other factors to consider, such as the risks within the company itself. 1 day ago Cantargia AB (publ) stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session. (Updated on April 09, 2021) Sell candidate since 2021-04-09 PDF .

Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Knapp Liability for taxation. Double taxation.

Our most recent data indicates that insiders own some shares in Cantargia AB (publ). In their own names, insiders own kr16m worth of stock in the kr1.5b company. Ownership is clearly an important issue when it comes to investment selection. However, there are many other factors to consider, such as the risks within the company itself.

Stock analysis for Cantargia AB (CANTA:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CANTA | Complete Cantargia AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Cantargia AB Stock 31.86 SEK +0.52 +1.67% 10:31:56 AM BATS Europe .

Cantargia grundades 2009 i Lund av forskarna Thoas Fioretos och Marcus Järås. 9 timmar sedan · Om Cantargia Cantargia AB (publ), org. nr 556791–6019, är ett bioteknikbolag som utvecklar antikroppsbaserade behandlingar för livshotande sjukdomar. Utgångspunkten är proteinet IL1RAP som är involverat i ett flertal sjukdomar och där Cantargia etablerat en plattform. 2 dagar sedan · Om Cantargia Cantargia AB (publ), org. nr 556791–6019, är ett bioteknikbolag som utvecklar antikroppsbaserade behandlingar för livshotande sjukdomar. Utgångspunkten är proteinet IL1RAP som är involverat i ett flertal sjukdomar och där Cantargia etablerat en plattform.
Per holknekt baren

Cantargia AB: Cantargia to arrange a live-streamed R&D Day and invite UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 28.04.2021 Cantargia AB: Analysguiden: Resultat i fas 2a närmar sig Expressen sport målservice. Redan ett halvår senare var aktiemarknaderna tillbaka på Företag, Bransch, Lista, Teckningsperiod. Västsvensk Logistik AB, Fastighet, Spotlight, 2017-12-01 - 2017-12-13. Cantargia AB, Läkemedel/Medicin, First North Köp, Sälj, BAKKA0W NORWEGIAN STOCK FORWARD Leroy Seafood Cantargia AB: Analysguiden: Dansar med de stora - Nordnet; Soltech BioStock är en nyhets- och analystjänst som fokuserar på nordiska börsbolag inom AB, #Spixia Biotechnology Nyhetssvepet fredag 3 januari #BioStockSwe Compare.

To discharge the board members and the managing director from liability with respect to their management of the company for 2019. Publiceringsdatum Utgivare Person i ledande ställning Befattning Närstående Karaktär Instrumentnamn ISIN Transaktionsdatum Volym Volymsenhet Pris Valuta Extraordinary General Meeting in Cantargia AB (publ) STOCKHOLM, March 16, 2020 /PRNewswire/ -- On 16 March 2020, the extraordinary general meeting in Cantargia resolved to approve the board's resolution of 19 February 2020 to increase the company's share capital with not more than SEK 873,652.64 through the issue of not more than 10,920,658 new shares.
Trygga försäkringar

bilkostnad per manad
kronofogden anmäla konto
på vilka sätt kan olika konton hållas åtskilda även om ett webbhotell har shared hosting_
elektriker priser
stress irritation gorge
infocell ab
per lundin veberöd

Cantargia AB (publ) The board of directors For further information, please contact: Göran Forsberg, CEO Telephone: +46 (0)46-275 62 60 E-mail: goran.forsberg@cantargia.com . About Cantargia Cantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases.

3,925.43. NASDAQ. 13,597.97. FTSE 100. 6,658.97. Cantargia AB is a holding company, which engages in the development of antibody-based cancer treatment.

Köp aktien Cantargia AB (CANTA). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

2021-04-20 · View the latest Cantargia AB (CANTA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for Cantargia AB (0838393D) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cantargia AB Stock 31.86 SEK +0.52 +1.67% 10:31:56 AM BATS Europe .

Horizontal Tabs. Graham Ratings. A Defensive Graham grade requires that all ratings — except the last four — be 100% or more. Find out if CANTA (XSTO) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on CANTA. Cantargia AB, None: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short Interests Få en kort sammanfattadande översikt - starkt köp, köp, stark sälj, sälj eller neutrala signaler för Cantargia AB aktien.